PFE starts phase-1/2 trial of Rituxan FoB: http://clinicaltrials.gov/ct2/show/NCT01526057 PFE is one of the few companies who has not embraced a partner for its FoB program. Thanks to Duncan Emerton (a/k/a Biosimilarz) for this find.